Abliva AB (ABLI) NPV

Sell:0.43 SEKBuy:0.44 SEK0.00 SEK (0.11%)

Prices delayed by at least 15 minutes
Sell:0.43 SEK
Buy:0.44 SEK
Change:0.00 SEK (0.11%)
Deal now
Prices delayed by at least 15 minutes
Sell:0.43 SEK
Buy:0.44 SEK
Change:0.00 SEK (0.11%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.

Key people

Ellen Donnelly
Chief Executive Officer
Catharina Jz Johansson
Deputy Chief Executive Officer, Chief Financial Officer, Secretary, Vice President Investor Relations
Eskil Elmer
Chief Scientific Officer
Dag Nesse
Vice President - Clinical Operations
Magnus Hansson
Chief Medical Officer
David Laskow-Pooley
Independent Chairman of the Board
Roger Franklin
Director
David Bejker
Independent Director
Denise Goode
Independent Director
Jan Toernell
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    SE0002575340
  • Market cap
    SEK 701.98m
  • Employees
    6
  • Shares in issue
    1.06bn
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.